Circulating Mitochondrial DNA in Patients in the ICU as a Marker of Mortality: Derivation and Validation

Abstract

Increased mtDNA levels are associated with ICU mortality, and inclusion of mtDNA level improves risk prediction in medical ICU patients. Our data suggest that mtDNA could serve as a viable plasma biomarker in medical ICU patients.